BF Biosciences starts production from new syringe line

MG News | November 14, 2024 at 03:21 PM GMT+05:00

0:00

November 14, 2024 (MLN): BF Biosciences Limited (PSX: BFBIO) has secured approval from Drug Regulatory of Pakistan (DRAP) for its brownfield expansion project along with commencement of commercial production from pre-filled syringes line.

BFBIO shared the development in its notice to the Pakistan Stock Exchange (PSX) on Thursday.

In continuation of the above, the company said the combi filling and lyophilization lines have been commissioned and commercial production has commenced.

Accordingly, the full Line II expansion project stands commissioned from today.

Furthermore, the company said it has already secured approvals for new products from DRAP and intends to launch these products in the coming months.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	172,929.34 426.44M	0.71% 1224.58
ALLSHR	103,374.80 969.71M	0.87% 892.69
KSE30	52,113.32 270.99M	0.73% 378.98
KMI30	248,767.62 211.31M	0.96% 2361.39
KMIALLSHR	67,164.92 511.94M	0.97% 647.39
BKTi	47,940.58 105.32M	0.30% 144.83
OGTi	36,303.00 18.48M	1.49% 531.61

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	81,230.00	81,995.00 80,925.00	-505.00 -0.62%
BRENT CRUDE	99.09	102.55 97.44	-2.18 -2.15%
RICHARDS BAY COAL MONTHLY	110.00	110.00 110.00	-3.85 -3.38%
ROTTERDAM COAL MONTHLY	105.50	105.50 105.45	0.75 0.72%
USD RBD PALM OLEIN	1,191.50	1,191.50 1,191.50	0.00 0.00%
CRUDE OIL - WTI	92.93	96.48 91.92	-2.15 -2.26%
SUGAR #11 WORLD	14.62	14.82 14.59	-0.19 -1.28%